Empaglin

Empaglin

Empagliflozin is a member of a group of medicines called sodium glucose  
  co-transporter-2 (SGLT2) inhibitors. Empagliflozin works by blocking the
  SGLT2 protein in your kidneys. This causes blood sugar (glucose) to be 
  removed in your urine. Thereby Empagliflozin lowers the amount of sugar in
  your blood. This medicine can also help prevent heart disease.

- Each film coated tablet of  Empaglin®  10 contains:
    Empagliflozin 10 mg. 
  - Each film coated tablet of  Empaglin®  25 contains:
    Empagliflozin 25 mg. 

Do not use Empaglin®.  
- if you are allergic to empagliflozin or any of the other ingredients of this 
   medicine

- Tell your doctor or pharmacist if you are taking, have recently taken or 
  might take any other medicines.
- if you are taking medicines that increase urine production (diuretics)
- if you are taking other medicines that lower the amount of sugar in your 
  blood such as insulin or a “sulphonylurea” medicine. Your doctor may want 
  to lower the dose of these other medicines, to prevent your blood sugar 
  levels from getting too low (hypoglycaemia).

If you are pregnant or breastfeeding, think you may be pregnant or are 
  planning to have a baby, ask your doctor or pharmacist for advice before 
  taking this medicine. Do not use Empaglin® if you are pregnant. It is unknown if Empaglin® is harmful to the unborn child.
  Do not use Empaglin® if you are breastfeeding. It is not known if 
  Empagliflozin passes into human breast milk.
 

Stop using the product and seek immediate medical attention if you 
develop urticaria, rash, tightness of the chest, wheezing, hypotension.
  Common side effects

- Low blood sugar (hypoglycaemia) 
- Urinary tract infection 
- Genital yeast infection (thrush) 
- Passing more urine than usual or needing to pass urine more often 
- Itching
-  Rash or red skin – this may be itchy and include raised bumps, oozing fluid 
  or blisters 
- Thirst 
- Blood tests may show an increase in blood fat (cholesterol) levels in your
  blood
  Uncommon side effects
- Hives 
- Straining or pain when emptying the bladder 
- Blood tests may show a decrease in kidney function (creatinine or urea)
- Blood tests may show increases in the amount of red blood cells in your blood
  (haematocrit)

Talk to your doctor, pharmacist or nurse before taking this medicine, and 
  during treatment:

- if you have “type 1 diabetes”. This type usually starts when you are young 
  and your body does not produce any insulin.
- if you experience rapid weight loss, feeling sick or being sick, stomach pain, 
  excessive thirst, fast and deep breathing, confusion, unusual sleepiness or 
  tiredness, a sweet smell to your breath, a sweet or metallic taste in your 
  mouth, or a different odour to your urine or sweat, contact a doctor or the 
  nearest hospital straight away. These symptoms could be a sign of “diabetic 
  ketoacidosis” – a rare, but serious, sometimes life-threatening problem you 
  can get with diabetes because of increased levels of “ketone bodies” in your 
  urine or blood, seen in tests. The risk of developing diabetic ketoacidosis may
  be increased with prolonged fasting, excessive alcohol consumption, 
  dehydration, sudden reductions in insulin dose, or a higher need of insulin due 
  to major surgery or serious illness. 
- if you have serious kidney or liver problems – your doctor may ask you to 
   take a different medicine.
- might be at risk of dehydration, for example: 
• if you are being sick, have diarrhoea or fever, or if you are not able to eat or 
   drink
• if you are taking medicines that increase urine production [diuretics] or lower 
  blood pressure or if you are over 75 years old. 
- if you have a serious infection of the kidney or the urinary tract with fever.  
  Your doctor may ask you to stop taking Empaglin® until you have recovered.
- Talk to your doctor immediately if you develop a combination of symptoms of 
  pain, tenderness, redness, or swelling of the genitals or the area between the 
  genitals and the anus with fever or feeling generally unwell. These symptoms
  could be a sign of a rare but serious or even life-threatening infection, called 
  necrotising fasciitis of the perineum or Fournier’s gangrene which destroys
  the tissue under the skin. Fournier’s gangrene has to be treated immediatelyChildren and adolescents: Empaglin® film coated tablet can be used in children aged 10 years and older for the treatment of type 2 diabetes. No data are available in children below 10 years of age
Empaglin® is not recommended for children and adolescents under 18 years of age for the treatment of heart failure or for the treatment of chronic kidney disease, because it has not been studied in these patients. 
 

- Empaglin®  25: pack of 3 blisters, blister of 10 tablets.
- Empaglin®  10: pack of 3 blisters, blister of 10 tablets.

- Store in a dry place at temperature not exceeding 25ºC.